Rua Bioscience has almost doubled its full-year loss as it works towards becoming a revenue-generating business.
The NZX-listed medical cannabis business posted a loss of $8.6 million for the 12 months ended June 30, down from a $4.4m loss in its 2021 financial year.
The business generated more
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
